Biology
Biology News
Elephant seal tracking reveals hidden lives of deep-diving animals
| 5/15/2012 | SANTA CRUZ, CA--Researchers at the University of California, Santa Cruz, who pioneered the use of satellite tags to monitor the migrations of elephant seals have compiled one of the largest datasets available for any marine mammal species, revealing their movements and diving behavior at sea in unprecedented detail. A new study published May 15 in the journal PLoS ONE focuses on the a... [Comments] |
UMD finding may hold key to Gaia hypothesis
| 5/15/2012 | Is Earth really a sort of giant living organism as the Gaia hypothesis predicts? A new discovery made at the University of Maryland may provide a key to answering this question. This key of sulfur could allow scientists to unlock heretofore hidden interactions between ocean organisms, atmosphere, and land -- interactions that might provide evidence supporting this famous theory. The Gaia... [Comments] |
Aware Provides Biometrics Software and Services for Three Large-Scale Border Management Systems
| 5/15/2012 | BEDFORD, Mass., May 15, 2012 Aware, Inc. (NASDAQ: AWRE ), a global provider of biometrics and medical imaging software, today announced that it is providing biometrics software and services for three large-scale border management systems as a result of separate team-based project wins in Europe, the Middle East, and North America. In each case, Aware is subcontracted to pr... [Comments] |
Undersea warriors, undersea medicine: The future force
| 5/15/2012 | ARLINGTON, Va.U.S. Navy divers take on dangerous tasks every dayand starting this week, they will be part of a multinational effort near Estonia to help clear the Baltic Sea of underwater mines left over from as long ago as the First and Second World Wars. "Open Spirit" will be among the biggest naval exercises in the Baltic Sea this year, where more than 150,000 naval mines were planted d... [Comments] |
Drugs from lizard saliva reduces the cravings for food
| 5/15/2012 | A drug made from the saliva of the Gila monster lizard is effective in reducing the craving for food. Researchers at the Sahlgrenska Academy, University of Gothenburg, have tested the drug on rats, who after treatment ceased their cravings for both food and chocolate. An increasing numbe... [Comments] |  |
Air pollution level changes in Beijing linked with biomarkers of cardiovascular disease
| 5/15/2012 | During the 2008 Beijing Olympics, changes in air pollution were associated with changes in biomarkers of systemic inflammation and thrombosis (formation of blood clot) as well as measures of cardiovascular physiology in healthy young persons, according to a study in the May 16 issue of JAMA, a theme issue on Global Health. "Air pollution is a risk factor for cardiovascular diseases (CVD... [Comments] |
Prenatal micronutrient, food supplementation intervention in Bangladesh decreases child death rate
| 5/15/2012 | Pregnant women in poor communities in Bangladesh who received multiple micronutrients, including iron and folic acid combined with early food supplementation, had substantially improved survival of their newborns, compared to women in a standard program that included usual food supplementation, according to a study in the May 16 issue of JAMA , a theme issue on Global Health. "Maternal a... [Comments] |
Considerable prevalence of both malaria, STIs exist among pregnant women in sub-Saharan Africa
| 5/15/2012 | A review of studies reporting estimates of the prevalence of sexually transmitted infections/reproductive tract infections (STIs/RTIs) and malaria over the past 20 years suggests that a considerable burden of malaria and STIs/RTIs exists among pregnant women attending antenatal (before birth) facilities in sub-Saharan Africa, according to a review and meta-analysis of previous studies publishe... [Comments] |
Biology Products
Mouse Anti-Snail, a.a. 150-39 Antibody, Unconjugated from CHEMICON
Description:Snail, a.a. 150-39...Company:CHEMICON
Rat Anti-Mouse IgM Heavy Chain Monoclonal Antibody, Unconjugated, Clone LO-MM-3 from Cell Sciences
Description:Anti-Mouse IgM Heavy Chain, Clone LO-MM-3, Monoclonal Antibody...Company:Cell Sciences
Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:HOXC11 Antibody...Company:ProSci, Inc
Rabbit Anti-BAFF-R (CT) BR3 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:BAFF-R (CT) BR3 Affinity Purified Polyclonal Antibody...Company:ProSci, Inc
Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:HOXC11 Antibody...Company:ProSci, Inc
Biology Technology
JoVE partners with US government to publish cutting-edge defense research
| 5/15/2012 | On May 15, 2012, JoVE ( Journal of Visualized Experiments ) will publish two articles in partnership with the United States government's Defense Threat Reduction Agency (DTRA). JoVE is proud to present the work from Temple University's Dr. Chris Schafmeister and State University of New... [Comments] |  |
New 'metamaterial' practical for optical advances
| 5/15/2012 | WEST LAFAYETTE, Ind. - Researchers have taken a step toward overcoming a key obstacle in commercializing "hyperbolic metamaterials," structures that could bring optical advances including ultrapowerful microscopes, computers and solar cells. The researchers have shown how to create the metamaterials without the traditional silver or gold previously required, said Alexandra Boltasseva, a... [Comments] |
Vermillion Reports First Quarter 2012 Results
| 5/15/2012 | AUSTIN, Texas, May 15, 2012 Vermillion, Inc. (NASDAQ: VRML ), a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012. Q1 2012 Operational Highlights In Q1, the volume of OVA1®, the company's flagship diagnostic test designed to help differentiate benign from malignant ovarian masses, was ge... [Comments] |
| 5/15/2012 | PARIS, May 15, 2012 OrbusNeich today announced that 12-month follow-up data from the REMEDEE study showed favorable clinical and safety outcomes involving the use of the company's Combo Dual Therapy Stent when compared to the TAXUS ® Liberte ® paclitaxel-eluting stent. The data were presented by Michael Haude, M.D., of Medical Clinic I at the Lukaskrankenhaus in... [Comments] |
Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019
| 5/15/2012 | NEW YORK, May 15, 2012 Reportlinker.com announces that a new market research report is available in its catalogue: Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019 http://www.reportlinker.com/p0606218/Neuroendocrine-Carcinoma-Therapeutics---Pipeline-Assessment-and-Market-Forecast-to-2019.html#utm_source=prnewswire&utm_medium=pr&... [Comments] |
(Date:5/16/2012)... Medbox, Inc. (Pinksheets: MDBX) ( www.medboxinc.com ) ... new, highly secure, automated kiosk for the storage ... which uses biometric fingerprint recognition, safely stores medicines ... The system also provides a permanent record of ... individual that obtained the medicine, the time of ...
(Date:5/16/2012)... experiments in the 1970s using electrical brain stimulation identified ... precise neuron-by-neuron pathway has not been described in any ... this pathway, Dr Edgar Buhl and colleagues in Bristol,s ... the Xenopus frog tadpole. , They ... just four types of neurons. By touching skin ...
(Date:5/16/2012)... , , Microscopes provide valuable insights in the structure ... remain in their natural environment. However, this is very ... of Technology (KIT), the Max Planck Institute for Polymer ... (NIH) have now developed a new method to visualize ... size in living fish larvae. It is published in ...
Breaking Biology News(10 mins):Medbox Developing a Patent Pending Wall-Mounted Biometric Kiosk for Storage of Sensitive Medicine Samples and Supplies for Doctor's Offices. 2Nature: Microscope looks into cells of living fish 2MIT researchers develop a better way to see molecules at work in living brain cells 15793 1MIT researchers develop a better way to see molecules at work in living brain cells 15793 2Nonin Medical Announces Its Second Generation Wrist Worn Device for European Distribution 3A Delivering Reliability in the Widest Range of Patient Pop 11552 1Nonin Medical Announces Its Second Generation Wrist Worn Device for European Distribution 3A Delivering Reliability in the Widest Range of Patient Pop 11552 2U M Receives NIH FDA Grant To Study Adaptive Clinical Trial Design 11547 1U M Receives NIH FDA Grant To Study Adaptive Clinical Trial Design 11547 2... in German . , Because of its ... tetrachloride, CCl4) can no longer be used or produced in ... other chlorinated hydrocarbons, such as chloroform (trichloromethane, CHCl3), also produce ... get rid of this unwanted substance? A team headed by ...
... more funds into the study of lipids the ,fatty, ... human cells and which are implicated in a range of ... such as cholesterol are known to play an important part ... cells contain thousands of different lipids which are also vital ...
... CA, June 16, 2008 -- VaxInnate Corporation announced today that ... and pandemic influenza vaccines during BIO 2008 here this week. ... following three BIO 2008 panel discussions: , On ... Preparing for the Next Pandemic," , 8:15-9:45 am in ...
Other Biology News:Fair trade 2Europe-wide investment in lipid research will help tackle disease, says new report 2VaxInnate to discuss seasonal and pandemic flu vaccines during BIO 2008 this week 2Mouse monoclonal [CAT-2] to Chloramphenicol Acetyltransferase...
... Immunogen corresponds to amino acids 2-105 ... has been successfully used in Western blot, ... blot, this antibody detects an ~ 60 ... has also been used in immunoprecipitation and ...
... Affi-Prep protein A media yield highly ... prior to analysis of other immunoglobulin ... antigen purification. Protein A binds to ... IgG from mammalian species. This ready-to-use, ...
Determin interaction of your protein with Echelons lipids...
Biology Products:(Date:5/14/2012)... 2012 More than one billion people worldwide have a ... the ability of the lens in the eye to change ... others struggle with trying to read menus and newspapers. Maybe ... this change in vision, which often begins around age 40, ... for lenses that are both multifocal and daily ...
(Date:5/14/2012)... Inc. (NYSE Amex: PTN ) a biopharmaceutical ... of diseases with significant unmet medical need and commercial ... March 31, 2012. Palatin reported a net loss of ... for the quarter ended March 31, 2012, compared to ... basic and diluted share, for the same period in ...
(Date:5/13/2012)... 2012 /PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ: SSRX ... biotechnology company focused on researching, developing, manufacturing and ... results for the first quarter ended March 31, ... Financial Highlights: , Total net ... of 2011 to RMB147.2 million (US$23.4 million), compared ...
(Date:5/11/2012)... May 11, 2012 The Canadian aerospace industry is ... and the European Community. In order to retain or ... and Concordia University must keep abreast of the ... Hoa, that means accelerating the scientific and technical know-how ... as Automated Fibre Placement (AFP). Now, thanks to the ...
Breaking Biology Technology:New Daily Disposable Multifocal Contact Lenses from CooperVision Offer Comfort, Performance, Health, and Convenience to Fit Your Life 2New Daily Disposable Multifocal Contact Lenses from CooperVision Offer Comfort, Performance, Health, and Convenience to Fit Your Life 3Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012 2Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012 3Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012 4Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012 53SBio Inc. Announces Unaudited First Quarter 2012 Results 23SBio Inc. Announces Unaudited First Quarter 2012 Results 33SBio Inc. Announces Unaudited First Quarter 2012 Results 43SBio Inc. Announces Unaudited First Quarter 2012 Results 53SBio Inc. Announces Unaudited First Quarter 2012 Results 63SBio Inc. Announces Unaudited First Quarter 2012 Results 73SBio Inc. Announces Unaudited First Quarter 2012 Results 83SBio Inc. Announces Unaudited First Quarter 2012 Results 93SBio Inc. Announces Unaudited First Quarter 2012 Results 103SBio Inc. Announces Unaudited First Quarter 2012 Results 11[0] New Daily Disposable Multifocal Contact Lenses from CooperVision Offer Comfort, Performance, Health, and Convenience to Fit Your Life[0] Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012[0] 3SBio Inc. Announces Unaudited First Quarter 2012 Results[0] The future of aerospace takes off in Montreal
... Netherlands, February 11, Agendia, a world leader in ... B. Carter as the company,s new Vice,President of ... "As we continue to grow as a global ... commented Dr. Bernhard Sixt, Ph.D., President and,Chief Executive ...
... Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ), a ... clinical-stage product candidates for central nervous system disorders, today ... ended December 31, 2008. Vanda reported a net ... 2008, compared to $10.9 million for the third quarter ...
... new product names that better reflect the unique properties and industry-leading ... ... February 11, 2009 -- Zeus, Inc. announces new product name changes ... products are unaltered in composition and processing. They remain the ...
Other Biology Technology:Agendia Appoints VP of Business Development 2Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 2Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 3Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 4Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 5Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 6Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 7Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 8Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 9Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 10Zeus Announces Product Name Changes 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |